Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

@article{Schmidt2005ElevatedNA,
  title={Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model},
  author={Henrik Schmidt and Lars Bastholt and Poul Flemming Geertsen and Ib Jarle Christensen and Susanne Larsen and Julie Gehl and Hans von der Maase},
  journal={British Journal of Cancer},
  year={2005},
  volume={93},
  pages={273 - 278}
}
We aimed to create a prognostic model in metastatic melanoma based on independent prognostic factors in 321 patients receiving interleukin-2 (IL-2)-based immunotherapy with a median follow-up time for patients currently alive of 52 months (range 15–189 months). The patients were treated as part of several phase II protocols and the majority received treatment with intermediate dose subcutaneous IL-2 and interferon-α. Neutrophil and monocyte counts, lactate dehydrogenase (LDH), number of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 116 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

What do we mean by validating a prognostic model?

Statistics in medicine • 2000
View 3 Excerpts
Highly Influenced

Cancer and the chemokine network

Nature Reviews Cancer • 2004
View 1 Excerpt

Electrochemotherapy with low-dose IL-2 in the treatment of disseminated malignant melanoma: Clinical and paraclinical evidence of systemic immune response

J Gehl, MH Andersen, H Hastrup, PT Straten, P Geertsen
Meet Proc ASCO 2003: • 2003
View 1 Excerpt

Similar Papers

Loading similar papers…